Thema: KR7009420001
Hanall Biopharma, KR7009420001
trading-7626924_1920.jpg - Foto: THN
Hanall Biopharma stock: Q3 net income rises 924.1% to KRW 3.1 billion
Hanall Biopharma stock is in focus after the company reported its third-quarter results. Revenue declined year on year, while operating income increased.
ad-hoc-news.de, heute 01:45 Uhr
Hanall Biopharma, KR7009420001
Hanall Biopharma launches Pangro Solution: KRW 2.2 trillion ...
Hanall Biopharma launched a 200 mL topical treatment on October 8, 2026. Hanall Biopharma stock has a KRW 2.2 trillion market value.
ad-hoc-news.de, 20.10.26 01:23 Uhr
Hanall Biopharma, KR7009420001
Hanall Biopharma stock reports 8.8 percent Q2 revenue growth ...
